Z-0489-2025 Class II Ongoing

Recalled by Roche Diagnostics Operations, Inc. — Indianapolis, IN

FDA device recall Z-0489-2025 was initiated by Roche Diagnostics Operations, Inc. on Oct 17, 2024 and is designated Class II. Reason for recall: Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias) The recall status is ongoing. Affected quantity: 458 units.

Recall details

Product Type
Devices
Report Date
Nov 27, 2024
Initiation Date
Oct 17, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
458 units

Product description

cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, in vitro test for total L-homocysteine

Reason for recall

Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)

Distribution pattern

US: NJ, TX, NY, FL, IN, TX, OK, SC, IA,

Code information

UDI/DI 04015630929979, Lot Number 747029, exp. 30-SEPT-2024

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0489-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0489-2025. Report a data issue: hello@regdatalab.com.